Dioxo-triazines as a novel series of cathepsin K inhibitors
摘要:
A novel dioxo-triazine series of cathepsin K inhibitors was identified from HTS. A rapid exploratory programme led to the discovery of potent and selective cathepsin K inhibitors, typified by compound 24 which displayed IC50 values of 17 nM against catK and >10,000 nM in catL, catB and catS assays. (C) 2010 Elsevier Ltd. All rights reserved.
[EN] COMPOUNDS AND METHODS FOR MODULATING FXR<br/>[FR] COMPOSÉS ET MÉTHODES DE MODULATION DE FXR
申请人:TERNS PHARMACEUTICALS INC
公开号:WO2022147448A1
公开(公告)日:2022-07-07
Disclosed herein are compounds that can be used as Farnesoid X Receptor (FXR) agonists, compositions containing these compounds and methods of use thereof.